H3Africa comes of age

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S3-S5

  Mensah, George A ^a   Peprah, Emmanuel K ^a   Sampson, Uchechukwu K A ^a   Cooper, Richard S ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CARDIOVASCULAR RISK; EDITORIAL; HEALTH CARE DELIVERY; HEALTH STATUS; HEALTH SURVEY; HEREDITY; HISTORY OF MEDICINE; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MEDICAL RESEARCH; CARDIOVASCULAR DISEASE; EDUCATION; GENETICS; GENOMICS; PROCEDURES; RESEARCH; TRENDS;

AFRICA; CARDIOVASCULAR DISEASES; EDUCATION; GENOMICS; HUMANS; RESEARCH;

EID: 84930026077     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296(5576): 2225-2229.
2. McVean G, Spencer CC, Chaix R. Perspectives on human genetic variation from the HapMap Project. PLoS Genet 2005; 1(4): e54.
3. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491(7422): 56-65.
4. Gurdasani D, Carstensen T, Tekola-Ayele F, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature 2015; 517(7534): 327-332.
5. National Institutes of Health. NIH and Wellcome Trust announce partnership to support population-based genome studies in Africa. NIH News 2010 June 22; Available at: URL: http://www.nih.gov/news/health/jun2010/nhgri-22.htm.
6. Owolabi MO, Mensah GA, Kimmel PL, et al. Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools. Cardiovasc J Afr 2014; 25(3): 134-136.
7. H3Africa Working Group. Harnessing genomic technologies toward improving health in Africa: Opportunities and challenges. Recommendations for the Human Heredity and Health in Africa (H3Africa) Initiative to the Wellcome Trust and the National Institutes of Health. National Human Genome Research Institute/National Institutes of Health 2011 January 31; Available at: URL: http://h3africa.org/images/PDF/h3africa-whitepaper.pdf.
8. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356(23): 2388-2398.
9. Capewell S, O'Flaherty M. What explains declining coronary mortality? Lessons and warnings. Heart 2008; 94(9): 1105-1108.
10. Cooper RS, Bovet P. Measures of health and disease in Africa: are current methods giving us useful information about trends in cardiovascular diseases? Prog Cardiovasc Dis 2013; 56(3): 270-277.
11. Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension 2015; 65(2): 291-298.
12. Kotowski IK, Pertsemlidis A, Luke A, et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 2006; 78(3): 410-422.
13. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329(5993): 841-845.
14. Genovese G, Friedman DJ, Pollak MR. APOL1 variants and kidney disease in people of recent African ancestry. Nat Rev Nephrol 2013; 9(4): 240-244.
15. Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369(23): 2183-2196.
16. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380(9841): 572-580.
17. Mensah GA, Kiley J, Mockrin SC, et al. National Heart, Lung, and Blood Institute Strategic Visioning: Setting an Agenda Together for the NHLBI of 2025. Am J Public Health 2015; e1-e4.